 |
인쇄하기
취소
|
Government to increase fines up to 200 million won
Starting next year, companies that were found to violate the regulation will be subject to a fine of up to 200 million from the current 50 million, according to the Korea Food and Drug Administration.
Under the revision of the Pharmaceutical Affairs Law, which was passed through the National Assembly, the KFDA may designate the clinical centers and bioequivalence testing labs.
The KFDA of...
Under the revision of the Pharmaceutical Affairs Law, which was passed through the National Assembly, the KFDA may designate the clinical centers and bioequivalence testing labs.
The KFDA of...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.